Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RNA as a drug target.

Martin J Drysdale1, Georg Lentzen, Natalia Matassova

  • 1Department of Chemistry, RiboTargets Ltd., Granta Park, Abington, Cambridge, CB1 6GB, UK.

Progress in Medicinal Chemistry
|January 23, 2003
PubMed
Summary

Novel drug discovery targeting RNA is crucial due to rising antimicrobial resistance. High-resolution structural data enables targeting RNA, with synthetic oxazolidinones demonstrating the potential for clinically useful drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing wound healing with synthetic hyaluronic acid injection in sutured incisions on BALB/c mice.

Folia medica·2025
Same author

Reversible Small Molecule Multivariant Ras Inhibitors Display Tunable Affinity for the Active and Inactive Forms of Ras.

Journal of medicinal chemistry·2025
Same author

Insights into the human cDNA: A descriptive study using library screening in yeast.

Journal, genetic engineering & biotechnology·2024
Same author

Cofactor binding triggers rapid conformational remodelling of the active site of a methyltransferase ribozyme.

The Journal of biological chemistry·2024
Same author

Flipped and Peer-Assisted teaching: a new model in virtual anatomy education.

BMC medical education·2024
Same author

Nanomaterial strategies in wound healing: A comprehensive review of nanoparticles, nanofibres and nanosheets.

International wound journal·2024

Area of Science:

  • Drug discovery and development
  • Antimicrobial resistance
  • RNA-targeted therapeutics

Background:

  • Increasing drug resistance in antiviral and antibacterial treatments necessitates novel therapeutic strategies.
  • Advancements in high-resolution structural data offer new opportunities for drug development.
  • Targeting RNA presents a promising avenue for overcoming current drug resistance challenges.

Purpose of the Study:

  • To highlight the potential of targeting RNA as a drug target in the face of rising antimicrobial resistance.
  • To showcase how structural data can inform the development of novel RNA-binding drugs.
  • To demonstrate the feasibility of developing clinically useful drugs by targeting RNA directly.

Main Methods:

  • Review of current challenges in antimicrobial drug resistance.

Related Experiment Videos

  • Analysis of the impact of high-resolution structural data on drug targeting.
  • Examination of existing RNA-binding antibiotics, including synthetic oxazolidinones.

    • Main Results:

    • High-resolution structural data is poised to significantly impact RNA-targeted drug discovery.
    • Synthetic oxazolidinones serve as a key example of successful RNA-binding antibiotics.
    • The development of selective and clinically useful drugs targeting RNA is achievable.

    Conclusions:

    • Targeting RNA directly offers a viable strategy to combat drug resistance.
    • Advancements in structural biology facilitate the design of novel RNA-targeting agents.
    • Synthetic oxazolidinones exemplify the clinical potential of RNA-directed therapeutics.